FROM A RELIABLE SOURCE

BENDAMUSTINE HCl (monohydrate & anhydrous CAS 3543-75-7) is used in antitumor chemotherapy based on the alkylation mechanism. Main therapeutic area is in hematology; single dosage or in combination with Rituximab.

THERAPEUTIC INDICATION: ONCOLOGY

For the treatment of chronic lymphocytic leukemia and lymphomas.

MARKET INFORMATION

Originator: MUNDIPHARMA
Originator product: RIBOMUSTIN^®Core patent exclusivities: Patents expired

YOUR ADVANTAGES

Oncology product with a “low side effects” profile
Good quality API with reliable supply

^{This article uses material from Wikipedia, which is released under the Creative Commons Attribution-Share-Alike License 3.0.}